Yazar "Turgut, Burhan" için PubMed İndeksli Yayın Koleksiyonu listeleme
-
Acute Kidney Injury in a Case of Purpura Fulminans Developing Secondary to Antithrombin 3 Deficiency
Özkan, Gülsüm; Emeksiz, Gaye Kübra; Atar, Reşit Volkan; Sedef, Samet; Kara, Sonat Pınar; Öznur, Meltem; Turgut, Burhan (Medical Assoc Nippon Medical Sch, 2018)Purpura fulminans associated with antithrombin 3 (AT 3) deficiency is very rare in adults and neonates. It can be categorized into three principal forms - neonatal, idiopathic and acute infectious. Purpura fulminans has ... -
Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study
Çiftçiler, Rafiye; Sevindik, Omur Gokmen; Tekgunduz, Ali Irfan Emre; Erkurt, Mehmet Ali; Vural, Filiz; Turgut, Burhan; Demirkan, Fatih (Galenos Yayincilik, 2019)Objective: Significant developments occurred in the clinical management of acute lymphoblastic leukemia (ALL) in adults in recent decades. However, treatment results are still not satisfactory, especially in routine practice. ... -
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience
Tekgündüz, Emre; Göker, Hakan; Kaynar, Leylagül; Sarı, İsmail; Pala, Çiğdem; Doğu, Mehmet Hilmi; Altuntaş, Fevzi; Turgut, Burhan (Cig Media Group, Lp, 2016)In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-positive acute lymphoblastic leukemia patients. The best results in terms of survival are achieved in patients who were ... -
CD4(+), CD25(+), FOXP3(+) T Regulatory Cell Levels in Obese, Asthmatic, Asthmatic Obese, and Healthy Children
Donma, Mustafa Metin; Karasu, Erkut; Özdilek, Burcu; Turgut, Burhan; Topçu, Birol; Nalbanto?lu, Burçin; Donma, Orkide (Springer/Plenum Publishers, 2015)The aim of this prospective case control study is to determine CD4(+), CD25(+), and FoxP3(+) T regulatory cells (Tregs) and T helper cells (Ths) in obese, asthmatic, asthmatic obese, and healthy children. Obese (n = 40), ... -
Comprehensive identification of erythrocyte membrane protein deficiency by 2D gel electrophoresis based proteomic analysis in hereditary elliptocytosis and spherocytosis
Demiralp, Duygu Ozel; Peker, Selen; Turgut, Burhan; Akar, Nejat (Wiley-V C H Verlag Gmbh, 2012)Purpose Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (1DE) may reveal qualitative or quantitative defects in red blood cell (RBC) membrane proteins, two-dimensional gel electrophoresis (2DE) can be used for ... -
Convalescent plasma therapy in patients with COVID-19
Altuntaş, Fevzi; Ata, Naim; Yigenoğlu, Tuğçe Nur; Başcı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Çelik, Osman; Turgut, Burhan (Pergamon-Elsevier Science Ltd, 2021)Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ... -
Convalescent plasma therapy in patients with COVID-19
Yigenoğlu, Tuğçe Nur; Hacıbekiroğlu, Tuba; Berber, İlhami; Dal, Mehmet Sinan; Baştürk, Abdulkadir; Namdaroğlu, Sinem; Altuntaş, Fevzi; Turgut, Burhan (Wiley, 2020)There are currently no licensed vaccines or therapeutics for COVID-19. Anti-SARS CoV-2 antibody-containing plasmas, obtained from the recovered individuals who had confirmed COVID-19, have been started to be collected using ... -
Convalescent plasma therapy in patients with COVID-19 (Letter)
Altuntaş, Fevzi; Yigenoğlu, Tuğçe Nur; Bascl, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Turgut, Burhan; Erkurt, Mehmet Ali (Pergamon-Elsevier Science Ltd, 2021)[No Abstract Available] -
COVID-19 clinical course and blood groups: Turkish population-based study
Dal, Mehmet Sinan; Ata, Naim; Altuntaş, Fevzi; Başcı, Semih; Yigenoğlu, Tuğçe Nur; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Tubitak Scientific & Technical Research Council Turkey, 2021)Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ... -
COVID-19 in hematopoietic cell transplant recipients
Altuntaş, Fevzi; Ata, Naim; Yigenoğlu, Tuğçe Nur; Başcı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Springernature, 2021)In this study, we aim to report the outcome of COVID-19 in hematopoietic cell transplant (HCT) recipients. HCT recipients (n = 32) with hematological disease and hospitalized for COVID-19 were included in the study. A ... -
The Diagnostic Utility of Flow Cytometry in Celiac Disease Presented Isolated Iron Deficiency Anemia
Mete, Rafet; Oran, Mustafa; Avcı, Burcu Altındağ; Turgut, Burhan (Aves, 2021)Background: Flow cytometric analysis of intestinal intraepithelial lymphocytes contributes to the diagnosis of celiac disease. Celiac disease may present with iron deficiency anemia alone which is considered as one of the ... -
Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia
Turgut, Burhan; Turgut, Nilda; Çelik, Yahya; Tekgündüz, Emre; Pamuk, Gülsüm Emel; Demir, Muzaffer (Elsevier, 2011)Background: Acute cerebral ischemia is caused by different pathophysiological mechanisms. The role of platelets and other blood cells can be different among the stroke subtypes. Methods: Seventy-two patients with acute ... -
Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
Yeşilaltay, Alpay; Değirmenci, Hasan; Bilgen, Türker; Şirin, Duygu Yaşar; Bayır, Duygu; Değirmenci, Pelin; Turgut, Burhan (Lippincott Williams & Wilkins, 2022)Background: We have aimed at exposing left ventricular diastolic functions and the presence of known genetic mutations for familial erythrocytosis, in patients who exhibit idiopathic erythrocytosis. Methods: Sixty-four ... -
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
Tombak, Anıl; Pepedil Tanrıkulu, Funda; Durusoy, Salih Sertaç; Dinçyürek, Hüseyin Derya; Kaya, Emin; Ümit, Elif Gülsüm; Ferhanoğlu, Burhan; Akpınar, Seval; Turgut, Burhan (Galenos Yayincilik, 2021)Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ... -
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report
Özatlı, D.; Giden, A.O.; Erkurt, M.A.; Korkmaz, S.; Başçı, S.; Ulaş, T.; Turgut, Burhan (Elsevier Ltd, 2023)Therapeutic apheresis is an extracorporeal treatment that selectively removes abnormal cells or harmful substances in the blood that are associated with or cause certain diseases. During the last decades the application ... -
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
Yigenoğlu, Tuğçe Nur; Başçı, Semih; Şahin, Derya; Ulaş, Turgay; Dal, Mehmet Sinan; Korkmaz, Serdal; Altuntaş, Fevzi; Turgut, Burhan (Pergamon-Elsevier Science Ltd, 2021)SARS-CoV-2 attaches to the angiotensin-converting enzyme 2 (ACE-2) receptor on human cells. The virus causes hypercytokinemia, capillary leak, pulmonary edema, acute respiratory distress syndrome, acute cardiac injury, and ... -
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Çekdemir, Demet; Güvenç, Serkan; Özdemirkıran, Füsun; Eser, Ali; Topts, Tayfur; Özkocaman, Vildan; Küçükkaya, Reyhan Diz; Tekinalp, Atakan; Turgut, Burhan (Galenos Yayincilik, 2019)Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total ... -
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Başcı, Semih; Ata, Naim; Altuntaş, Fevzi; Yigenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Sage Publications Ltd, 2020)Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ... -
The outcome of COVID-19 in patients with hematological malignancy
Yigenoğlu, Tuğçe Nur; Ata, Naim; Altuntaş, Fevzi; Başçı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Wiley, 2021)In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 ... -
The outcome of COVID-19 in patients with hematological malignancy (Letter)
Yigenoğlu, Tuğçe Nur; Başçı, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Turgut, Burhan; Altuntaş, Fevzi (Wiley, 2021)[No Abstract Available]